. 2016 Nov 25;7(2):119–136. doi: 10.1016/j.apsb.2016.06.003
© 2017 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Scheme 1.
The final coupling reactions of eribulin.